,

The Future of Drug Discovery

Who Decides Which Diseases to Treat?

Specificaties
Paperback, blz. | Engels
Elsevier Science | e druk, 2013
ISBN13: 9780124071803
Rubricering
Elsevier Science e druk, 2013 9780124071803
€ 48,94
Levertijd ongeveer 8 werkdagen

Samenvatting

The Future of Drug Discovery: Who decides which diseases to treat? provides a timely and detailed look at the efforts of the pharmaceutical industry and how they relate, or should relate, to societal needs. The authors posit that as a result of increasing risk aversion and accelerated savings in research and development, the industry is not developing drugs for increasingly prevalent diseases, such as Alzheimer’s disease, untreatable pain, antibiotics and more. This book carefully exposes the gap between the medicines and therapies we need and the current business path. By analyzing the situation and discussing prospects for the next decade, the The Future of Drug Discovery is a timely book for all those who care about the development needs for drugs for disease.

Specificaties

ISBN13:9780124071803
Taal:Engels
Bindwijze:Paperback

Inhoudsopgave

<p>00 – Introduction for the non-specialist</p> <p>01 – Why there will be new drugs despite the ongoing ‘crisis’ of drug development in big pharma</p> <p>02 – The need for medicine grows</p> <p>03 – Medicines are becoming better </p> <p>04 – Which diseases do we want to treat?</p> <p>05 – Therapeutic Areas: strategically important diseases for the future</p> <p>06 – Blockbuster proprietary drugs versus generic drugs</p> <p>07 – Why is pharma a special industry?</p> <p>08 – Diagnosing towards personalized medicine</p> <p>09 – Personalized medicine</p> <p>10 – How much can drugs cost?</p> <p>11 – Modeling Drug Discovery until 2025</p> <p>12 – Drug development models between 2010 and 2025</p>
€ 48,94
Levertijd ongeveer 8 werkdagen

Rubrieken

    Personen

      Trefwoorden

        The Future of Drug Discovery